Disease ID | Disease name | Source of annotation with CYP11A1 | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
613743 | ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | CYP11A1 |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Ovarian steroidogenesis | hsa04913 | 7.07 |
Metabolic pathways | hsa01100 | 2.49 |
Steroid hormone biosynthesis | hsa00140 | 6.93 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 7.08 |
Metabolism of steroid hormones and vitamin D | R-HSA-196071 | 7.89 |
Biological oxidations | R-HSA-211859 | 5.55 |
Pregnenolone biosynthesis | R-HSA-196108 | 9.81 |
Diseases of metabolism | R-HSA-5668914 | 6.57 |
Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) | R-HSA-5579026 | 10.98 |
Phase 1 - Functionalization of compounds | R-HSA-211945 | 6.7 |
Metabolism | R-HSA-1430728 | 2.34 |
Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 7.85 |
Metabolism of lipids and lipoproteins | R-HSA-556833 | 3.79 |
Endogenous sterols | R-HSA-211976 | 8.46 |
Disease | R-HSA-1643685 | 3.33 |
GO term | GO ID | GO IC |
---|---|---|
cation binding | GO:0043169 | 1.4 |
monooxygenase activity | GO:0004497 | 5.1 |
steroid hydroxylase activity | GO:0008395 | 6.3 |
transition metal ion binding | GO:0046914 | 2.48 |
heme binding | GO:0020037 | 4.86 |
tetrapyrrole binding | GO:0046906 | 4.8 |
metal ion binding | GO:0046872 | 1.41 |
organic cyclic compound binding | GO:0097159 | 1.05 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | GO:0016705 | 4.65 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | GO:0016713 | 7.79 |
ion binding | GO:0043167 | 1.36 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | GO:0016709 | 6.07 |
catalytic activity | GO:0003824 | 1.05 |
binding | GO:0005488 | 0.18 |
iron ion binding | GO:0005506 | 4.65 |
cholesterol monooxygenase (side-chain-cleaving) activity | GO:0008386 | 9.74 |
heterocyclic compound binding | GO:1901363 | 1.06 |
oxidoreductase activity | GO:0016491 | 3.12 |